DK1542968T3 - Fremgangsmåde til fremstilling af mellemforbindelser - Google Patents

Fremgangsmåde til fremstilling af mellemforbindelser

Info

Publication number
DK1542968T3
DK1542968T3 DK03755559T DK03755559T DK1542968T3 DK 1542968 T3 DK1542968 T3 DK 1542968T3 DK 03755559 T DK03755559 T DK 03755559T DK 03755559 T DK03755559 T DK 03755559T DK 1542968 T3 DK1542968 T3 DK 1542968T3
Authority
DK
Denmark
Prior art keywords
preparation
intermediate compounds
intermediates
lactarn
directed
Prior art date
Application number
DK03755559T
Other languages
Danish (da)
English (en)
Inventor
Prasad Koteswara Kapa
Xinglong Jiang
Eric M Loeser
Joel Slade
Mahavir Prashad
George Tien-San Lee
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1542968T3 publication Critical patent/DK1542968T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Press Drives And Press Lines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK03755559T 2002-09-19 2003-09-18 Fremgangsmåde til fremstilling af mellemforbindelser DK1542968T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41192002P 2002-09-19 2002-09-19
US48024203P 2003-06-20 2003-06-20
PCT/EP2003/010416 WO2004026824A1 (en) 2002-09-19 2003-09-18 Process for preparing intermediates

Publications (1)

Publication Number Publication Date
DK1542968T3 true DK1542968T3 (da) 2009-04-20

Family

ID=32033579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03755559T DK1542968T3 (da) 2002-09-19 2003-09-18 Fremgangsmåde til fremstilling af mellemforbindelser

Country Status (21)

Country Link
US (1) US7589216B2 (ja)
EP (1) EP1542968B1 (ja)
JP (1) JP2006503053A (ja)
KR (1) KR20050057429A (ja)
CN (1) CN100439334C (ja)
AT (1) ATE417826T1 (ja)
AU (1) AU2003273404B2 (ja)
BR (1) BR0314592A (ja)
CA (1) CA2499426A1 (ja)
DE (1) DE60325390D1 (ja)
DK (1) DK1542968T3 (ja)
EC (1) ECSP055692A (ja)
ES (1) ES2321504T3 (ja)
HK (1) HK1079513A1 (ja)
MX (1) MXPA05003089A (ja)
NO (1) NO20051867D0 (ja)
NZ (1) NZ538833A (ja)
PL (1) PL374961A1 (ja)
PT (1) PT1542968E (ja)
RU (1) RU2374227C2 (ja)
WO (1) WO2004026824A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1406893B1 (en) 2001-06-15 2007-04-18 Vicuron Pharmaceuticals, Inc. Pyrrolidine bicyclic compounds
NZ538833A (en) 2002-09-19 2008-05-30 Novartis Ag Process for preparing intermediates
CN101092342A (zh) 2003-02-21 2007-12-26 诺瓦提斯公司 制备用以获得n-甲酰基羟胺的中间体的化学方法
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
CN101434570B (zh) * 2007-11-16 2011-02-02 上海医药工业研究院 吡咯烷衍生物及其制备方法和应用
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123465A (en) * 1975-10-16 1978-10-31 Hoffmann-La Roche Inc. Chiral tertiary phosphines
JPS5377010A (en) * 1976-12-16 1978-07-08 Mitsui Toatsu Chem Inc Preparation of hydroxypivalic acid
JPS6030666B2 (ja) * 1980-08-20 1985-07-17 鐘淵化学工業株式会社 光学活性メルカプトカルボン酸の製造法
JPS5953839B2 (ja) * 1980-10-06 1984-12-27 鐘淵化学工業株式会社 (−)−α−ヒドロキシメチル酪酸の製造方法
JPH01149751A (ja) * 1987-12-08 1989-06-12 Agency Of Ind Science & Technol 2−n−ヘキシル−3−ヒドロキシ−n−デカン酸及びそのエステル
AU633260B2 (en) 1988-08-09 1993-01-28 Genencor International, Inc. Chiral hydroxycarboxylic acids from prochiral diols
JPH0592948A (ja) * 1991-02-06 1993-04-16 Yoshitomi Pharmaceut Ind Ltd プロピオン酸アミド誘導体およびその医薬用途
BR9907689A (pt) * 1998-02-07 2000-11-14 British Biotech Pharm Agentes antibacterianos
US6977141B2 (en) * 1998-02-10 2005-12-20 Vicuron Pharmaceuticals Inc. Direct adsorption scintillation assay for measuring enzyme activity and assaying biochemical processes
AR032920A1 (es) * 2001-03-01 2003-12-03 Smithkline Beecham Corp Compuestos inhibidores de las peptido-deformilasas y medios para tratar infecciones bacterianas utilizando dichos inhibidores
EP1406893B1 (en) * 2001-06-15 2007-04-18 Vicuron Pharmaceuticals, Inc. Pyrrolidine bicyclic compounds
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
JP2006052138A (ja) * 2002-08-23 2006-02-23 Dainippon Sumitomo Pharma Co Ltd プロリン誘導体
NZ538833A (en) 2002-09-19 2008-05-30 Novartis Ag Process for preparing intermediates
CN101092342A (zh) 2003-02-21 2007-12-26 诺瓦提斯公司 制备用以获得n-甲酰基羟胺的中间体的化学方法
TW200427458A (en) 2003-04-02 2004-12-16 Novartis Ag Crystalline N-formyl hydroxylamine compounds
JP2009513485A (ja) 2003-06-26 2009-04-02 ノバルティス アクチエンゲゼルシャフト ある種の抗菌性n−ホルミルヒドロキシルアミン化合物の製造に有用な中間体の製造法

Also Published As

Publication number Publication date
PL374961A1 (en) 2005-11-14
PT1542968E (pt) 2009-03-25
AU2003273404A1 (en) 2004-04-08
ES2321504T3 (es) 2009-06-08
JP2006503053A (ja) 2006-01-26
WO2004026824A1 (en) 2004-04-01
US7589216B2 (en) 2009-09-15
MXPA05003089A (es) 2005-05-27
AU2003273404B2 (en) 2008-05-22
CA2499426A1 (en) 2004-04-01
NZ538833A (en) 2008-05-30
CN100439334C (zh) 2008-12-03
CN1684945A (zh) 2005-10-19
RU2005111600A (ru) 2006-10-27
NO20051867L (no) 2005-04-18
ECSP055692A (es) 2005-07-06
HK1079513A1 (en) 2006-04-07
BR0314592A (pt) 2005-08-09
ATE417826T1 (de) 2009-01-15
DE60325390D1 (de) 2009-01-29
US20050261504A1 (en) 2005-11-24
KR20050057429A (ko) 2005-06-16
RU2374227C2 (ru) 2009-11-27
NO20051867D0 (no) 2005-04-18
EP1542968A1 (en) 2005-06-22
EP1542968B1 (en) 2008-12-17

Similar Documents

Publication Publication Date Title
EA201992601A1 (ru) Конденсированное имидазопиперидиновое соединение, являющееся ингибитором jak
ATE411030T1 (de) Phosphonatanaloga von hiv- integrasehemmerverbindungen
ECSP066721A (es) Inhibidores novedosos de quimasa
ATE440833T1 (de) Antithrombotische diamide
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
SE0201635D0 (sv) Novel compounds
UY28290A1 (es) Compuestos farmacéuticos novedosos
SE0303180D0 (sv) Novel compounds
NO20044221L (no) Nye forbindelser
SE0302232D0 (sv) Novel Compounds
UY28625A1 (es) Nuevos compuestos farmacéuticos
EA200870358A1 (ru) 2-(циклический амино) пиримидоновые производные в качестве ингибиторов tpk1
DK1951747T3 (da) Fremgangsmåde og mellemprodukter til syntese af caspofungin
DK1491540T3 (da) Intermediater, der er anvendelige til syntese af pyridazinon-aldosereduktase inhibitorer
NO20071937L (no) Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer
BRPI0710199A2 (pt) Processo para preparação de inibidores de hiv protease
NO20051867D0 (no) Fremgangsmate for fremstilling av intermediater
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
NO20080661L (no) Nye cystein-protease-inhibitorer og deres terapeutiske anvendelser
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase
MXPA05012004A (es) Nuevos bioisosteros de actinonina.
DE602004031878D1 (de) Immunhemmende pyrazolon-verbindungen
DK1873152T3 (da) Hidtil ukendt fremgangsmåde til oprensning af Moxonidin
MXPA05014217A (es) Proceso para preparar intermediarios utiles para preparar ciertas n-formil hidroxilaminas antibacterianas.
ATE440848T1 (de) Synthese von proteaseinhibitorvorstufen